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AbstrACt
background National European cancer survival rates vary 
widely. Prolonged diagnostic intervals are thought to be 
a key factor in explaining these variations. Primary care 
practitioners (PCPs) frequently play a crucial role during 
initial cancer diagnosis; their knowledge could be used 
to improve the planning of more effective approaches to 
earlier cancer diagnosis.
Objectives This study sought the views of PCPs from 
across Europe on how they thought the timeliness of 
cancer diagnosis could be improved.
Design In an online survey, a final open-ended question 
asked PCPs how they thought the speed of diagnosis 
of cancer in primary care could be improved. Thematic 
analysis was used to analyse the data.
setting A primary care study, with participating centres in 
20 European countries.
Participants A total of 1352 PCPs answered the final 
survey question, with a median of 48 per country.
results The main themes identified were: patient-related 
factors, including health education; care provider-related 
factors, including continuing medical education; improving 
communication and interprofessional partnership, 
particularly between primary and secondary care; factors 
relating to health system organisation and policies, 
including improving access to healthcare; easier primary 
care access to diagnostic tests; and use of information 
technology. Re-allocation of funding to support timely 
diagnosis was seen as an issue affecting all of these.
Conclusions To achieve more timely cancer diagnosis, 
health systems need to facilitate earlier patient 
presentation through education and better access to 
care, have well-educated clinicians with good access 
to investigations and better information technology, and 
adequate primary care cancer diagnostic pathway funding.
IntrODuCtIOn
Cancer survival rates vary widely in Europe,1 
leading to considerable additional mortality 
in some countries. Data from the European 
Cancer Registry-based Study on Survival and 
Care of Cancer Patients (EUROCARE-5) show 
that the national 1-year relative survival rates 
for all cancer sites vary from 58.2% to 81.1%.2 
Poorer 1-year relative survival is thought to 
be indicative of diagnostic delay3 4 and more 
advanced disease at diagnosis,5 6 although it 
can be affected by differences in registration, 
as well as overdiagnosis and lead-time biases.7 8 
There may also be geographical differences 
in the incidence of cancers that have a poorer 
prognosis,9 as well as national variations in 
access to effective cancer treatment,10 and 
in levels of poverty, which in itself has been 
linked with more advanced disease stage at 
diagnosis.11–13 More advanced cancers are 
more difficult to treat successfully14 and, for 
strengths and limitations of this study
 ► We recruited primary care practitioners (PCPs) from 
20 European countries, 4 countries from each of the 
Northern, Southern, Eastern, Western and Central 
European geographical areas, to provide variation in 
geography, health systems and levels of healthcare 
spending.
 ► The recruitment method allowed participation of 
physicians in countries in which PCPs are un-
der-represented in research.
 ► The survey had only one question that related di-
rectly to PCPs’ views on the timeliness of cancer 
diagnosis.
 ► Neither patients, secondary care nor other primary 
care health professionals were included in the sur-
vey, and these groups may have had other insights 
to offer.
Protected by copyright.
 o
n
 O
ctober 4, 2019 at Universitaetsbibliothek Bern.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2019-030169 on 24 September 2019. Downloaded from 
s
o
u
r
c
e
:
 
ht
tp
s:
//
do
i.
or
g/
10
.7
89
2/
bo
ri
s.
13
36
97
 
| 
do
wn
lo
ad
ed
: 
4.
12
.2
01
9
2 Harris M, et al. BMJ Open 2019;9:e030169. doi:10.1136/bmjopen-2019-030169
Open access 
many cancers, the stage of disease at diagnosis is related 
to survival.15 16 There is considerable evidence that longer 
time to diagnosis and treatment has an adverse impact 
on cancer mortality.17–23 Timely care also adds to patients’ 
quality of life and emotional well-being.24 In addition, 
patients’ descriptions of the quality of their care are 
closely related to the speed of their diagnosis and treat-
ment; this is because they are concerned that longer waits 
might allow time for their cancers to grow.25
Timely diagnosis of cancer has therefore been an 
important aim of healthcare providers across Europe.25 
However, the challenge in deciding where and how to 
achieve this is substantial.26 In countries where a compar-
atively low 1-year cancer survival suggests that late diag-
nosis may be a major factor, it is uncertain whether this 
is due to patients presenting later to healthcare, whether 
they are not being referred quickly enough by those in 
primary care, or whether they are not being investigated 
and managed efficiently in secondary care.14 This may be 
a particular problem where patients with cancer present 
without red-flag symptoms, as how their primary care 
practitioners (PCPs) act depends on how their health 
systems are organised.27
Doctors and their patients recognise that general 
practitioners (GPs) and other PCPs have a key role in 
cancer detection.28–30 It has been suggested that PCPs’ 
knowledge of their patient populations can be used to 
improve health service design31 and the planning for 
more effective approaches to earlier cancer recognition 
and referral.32 There has been a call for research in this 
field15; although PCPs’ experience of their own health 
systems could potentially help to improve the planning of 
more effective approaches to earlier cancer recognition 
and referral, their perceptions have not been previously 
evaluated.
The aim of this study was to elicit the views of GPs and 
other PCPs from across Europe on how they thought the 
timeliness of cancer diagnosis could be improved.
MethODs AnD DesIgn
Design
Between November 2015 and December 2016, we 
performed an online survey of PCPs in 20 European 
countries. The methodology of the study is described in 
our published protocol paper.33
Development of the questionnaire
The Örenäs Research Group is a European group of 
primary care researchers that studies the primary care 
factors that relate to cancer survival. After a literature 
review, Örenäs Research Group investigators developed 
a questionnaire designed to elicit PCPs’ referral decisions 
on patients who could have cancer, and their degree of 
agreement with items relating to health system aspects 
that could affect their decision to refer patients with 
potential cancer symptoms for further investigation. The 
final, open-ended question asked: “How do you think the 
speed of diagnosis of cancer in primary care could be 
improved?” The answers to this question are used in this 
analysis.
The questionnaire was piloted twice by PCPs in 16 
Örenäs Research Group centres. No changes were made 
to the final, open-ended question after either of the 
piloting stages. Örenäs Research Group leads arranged 
for translations of the questionnaire into their local 
languages where these were not English, a total of 19 
translations from the original English. Translation, vali-
dation by back-translation to assess semantic and concep-
tual equivalence, and cultural adaptation34 of the survey 
were done in a standardised way35 and are described 
elsewhere.36 The questionnaires were put online using 
SurveyMonkey (SurveyMonkey, California, USA).
Participants and recruitment
The study was conducted in 25 Örenäs Research Group 
centres in 20 countries across Europe: Bulgaria, Croatia, 
Denmark, England, Finland, France, Germany, Greece, 
Israel, Italy, The Netherlands, Norway, Poland, Portugal, 
Romania, Scotland, Slovenia, Spain, Sweden and Swit-
zerland. Local study leads were asked to either gain 
ethical approval or obtain a statement that formal ethical 
approval was not needed in their jurisdiction (see online 
supplementary file).
Criterion sampling was used,37 with subjects being 
eligible for the survey if they were doctors working mainly 
in primary care. These doctors, referred to collectively 
here as ‘PCPs’, consisted of GPs as well as other doctors 
who had specialist training but worked in the commu-
nity and could be accessed directly by patients without 
referral.
Each Örenäs Research Group local lead was asked to 
email a survey invitation to the PCPs in their local health 
district, and to recruit at least 50 participants, with no 
maximum limit. This allowed recruitment of a varied 
sample with regard to gender, years since graduation, 
site of practice (urban, rural, remote) and size of prac-
tice. Consent was implied by agreeing to take part in the 
survey.
Data analysis
Local Örenäs Research Group leads translated the 
responses from their own languages into English and 
sent them to MH, who asked them for more information 
where the translation or context was unclear.
We used inductive thematic analysis,38 an approach in 
which codes and themes are suggested by the data rather 
than by a theoretical framework. The phases of analysis 
included coding, followed by the identification and clus-
tering of themes and subthemes, and the production of a 
descriptive thematic summary. Two researchers (MH and 
SH) independently coded the data from three countries 
and compared their analyses for inconsistencies and agree-
ment. MH then coded the data from the other countries. 
Team members from seven participating countries (ME, 
MH, RH, TK, ALN, DP, HT, all PCPs) then independently 
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Table 1 National distribution of primary care practitioners 
(PCPs) who responded to the question “How do you think 
the speed of diagnosis of cancer in primary care could be 
improved?”
Country
Number of PCPs 
who completed 
the survey
Number who answered 
the open-ended 
question (% of all survey 
completers)
Bulgaria 52 45 (86.5)
Croatia 56 42 (75.0)
Denmark 92 71 (77.2)
England 62 25 (40.3)
Finland 61 39 (63.9)
France 52 35 (67.3)
Germany 91 31 (34.1)
Greece 59 50 (84.7)
Israel 58 42 (72.4)
Italy 60 52 (86.7)
The 
Netherlands
108 84 (77.8)
Norway 81 46 (56.8)
Poland 135 103 (76.3)
Portugal 59 46 (78.0)
Romania 146 132 (90.4)
Scotland 62 55 (88.7)
Slovenia 91 52 (57.1)
Spain 380 332 (87.4)
Sweden 68 55 (80.9)
Switzerland 60 15 (25.0)
Total 1833 1352 (73.8)
Table 2 Demographic distribution of primary care 
practitioners who responded to the question “How do you 
think the speed of diagnosis of cancer in primary care could 
be improved?”
Demographic Number (%)
Gender
  Female 833 (61.6)
  Male 513 (38.0)
  Not stated 5 (0.4)
Years since graduation
  <10 192 (14.2)
  10–19 356 (26.4)
  20–29 416 (30.8)
  30–39 336 (24.9)
  40 or over 47 (3.5)
  Not stated 4 (0.3)
Site of practice
  Urban 816 (60.4)
  Rural 314 (23.2)
  Island 25 (1.9)
  Mixed 194 (14.4)
  Not stated 2 (0.1)
Number of doctors in practice
  1–2 337 (24.9)
  3–5 344 (25.5)
  6–9 290 (21.5)
  10 or more 374 (27.7)
  Not stated 6 (0.4)
considered themes and subthemes, discussed these and 
came to a consensus over the course of two meetings. 
The themes and subthemes were grouped to construct an 
interpretative narrative across the dataset and depicted 
diagrammatically. Apart from SH, a Masters psychology 
student, all authors involved in the coding and thematic 
analysis were experienced GPs who were also active in 
primary care research.
Patient and public involvement
There was no patient or public involvement in this study.
results
A total of 1833 PCPs completed the full questionnaire, 
with a median response rate per country of 24.8% (range 
7.1%–65.6%). All participating centres received at least 
50 responses, with a median of 61 PCPs per country. In 
all, 1352 PCPs (73.8% of completers) gave an answer to 
the final, open-ended survey question ‘How could the 
speed of diagnosis of cancer in primary care could be 
improved?’, with a median of 48 per country (table 1). 
To reduce the risk of bias from countries with larger 
numbers of respondents, we coded a maximum of 100 
respondents’ comments, randomly sampled, per country. 
The demographic distributions of the PCPs answering 
this final survey question are shown in table 2. Towards 
the end of the analysis, no new themes emerged.
We identified four main themes organising the content 
of the responses to the final survey question: patient-re-
lated factors, care provider-related features, improving 
communication and interprofessional partnership and 
aspects of health system organisation and health poli-
cies. Two structural facets transcended the four themes: 
accessing diagnostic tests and using information tech-
nology. The issue of allocating funding to support timely 
diagnosis fed into all the other themes. The themes 
are shown diagrammatically in figure 1. Themes and 
subthemes are described below, with participant quota-
tions identified by country and a participant number.
Patient-related factors
This theme included ideas on education and training to 
improve patient knowledge. Many PCPs advocated the 
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Figure 1 Diagrammatic representation of themes emerging from responses to the question “How do you think the speed of 
diagnosis of cancer in primary care could be improved?” PCP, primary care practitioner.
use of health education and media campaigns to improve 
patient awareness of alarm symptoms and signs:
By giving patients better information about when 
to go to a doctor—reduce patient delay. (Denmark, 
PCP69)
Improve health literacy of patients regarding the de-
tection of early symptoms that might indicate onco-
logical disease. (Portugal, PCP37)
Targeting advice on cancer risks was also considered 
important:
Informing patients about cancer risks related to their 
age groups. (Italy, PCP28)
However, public health messages could be seen as 
unworkable:
Stop public campaigns telling everyone with a partic-
ular symptom they need for example, a chest X-ray 
after 3 weeks of cough—inappropriately blocking the 
service. (Scotland, PCP16)
Care provider-related factors
PCPs had suggestions on how to improve their own knowl-
edge and that of other caregivers, by both increasing 
the amount of the training and improving the teaching 
content. Improving the training of PCPs and other 
healthcare professionals was considered by many respon-
dents to be important:
By educating healthcare professionals. When to sus-
pect and when to do further tests? (Finland, PCP33)
CME [continuing medical education] on early signs 
and up-to-date investigation processes. (Sweden, 
PCP52)
Alertness in their role was also considered key:
Often the presence of alarm signs is too late … Be 
alert and listen to the patients. (Spain, PCP46)
Primary care doctors also need to be aware of the rele-
vant clinical pathways:
Training of GPs … taking into account the en-
tire pathway from symptom to diagnosis. (Poland, 
PCP17)
PCPs thought it important that cancer screening and 
referral guidelines should be clear, and that they them-
selves should be involved in designing them.
Clear guidelines regarding cancer alarm signs and re-
ferral indications. (Finland, PCP37)
GPs who design guidelines together with specialists. 
(Sweden, PCP21)
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Improving communication and interprofessional partnership
Patient-PCP communication improvements and enhance-
ments to interprofessional partnerships were frequently 
suggested by the PCP respondents. Improving communi-
cation with patients was considered important, although 
this implied having longer consultations:
GPs should pay more attention when they speak to 
patients. (Italy, PCP26)
Longer consultations to allow more thorough assess-
ment without pressure of time. (Scotland, PCP5)
Improving the interaction within the practice team 
could also be helpful:
Discussion in the team about recent referrals so the 
team benchmarks itself. (England, PCP22)
A lot can be learnt from colleagues’ experiences of 
missed diagnoses. (The Netherlands, PCP40)
Improving partnership between PCPs and other 
primary healthcare professionals, for example, nurses 
and healthcare assistants, with adequate training, was also 
considered important:
Involve the nurses in gathering the patient’s medical 
history. (Poland, PCP20)
Good training of healthcare assistant to identify risk 
symptoms. (Norway, PCP1)
Improving the relationship between primary and 
secondary care doctors, with easier and reliable commu-
nication between the two, was highlighted:
Easy communication with specialists (and, in my case, 
preferably email contact). (The Netherlands, PCP85)
It is essential to establish a communication channel 
between primary healthcare and specialist healthcare 
so that critical patients would not get lost in the sys-
tem. (Croatia, PCP36)
Joint working with public health departments was also 
considered valuable:
With the cooperation between the National Institute 
of Public Health and family medicine specialists, who 
know their patients best. (Croatia, PCP38)
Many doctors commented on the importance of conti-
nuity of care:
Knowing your patient well. Consequently, not 
having three different GPs for one patient. (The 
Netherlands, PCP69)
strengthening system organisation and improving health 
policy
Strengthening how health systems are organised and 
implementing health policies that allow timely cancer 
diagnosis were key recommendations from many PCPs. 
Enhancing patient access to primary care, particularly 
for vulnerable or more remote groups, was considered 
important by some:
Shorter queues to GP appointment in order to start 
assessments without delay. (Finland, PCP33)
In some places (rural, inland) inaccessibility to 
MCDTs [screening examinations] can be an obstacle. 
Portugal, PCP43)
Practical steps to improve access to secondary care were 
also seen as key, particularly those relating to costs to the 
patient:
Access to specialists must be cheaper. (Romania, 
PCP99)
Patient-friendly hospital services—so that the ap-
pointments are not too stressful or expensive (travel 
and parking). (England, PCP19)
Many PCPs commented on the need for better working 
conditions, a larger workforce, a reduced workload and 
less bureaucracy:
A sufficient number of healthcare professionals 
so that there is not too much workload for a few. 
(Croatia, PCP5)
Reduction of the workload at the family medicine 
doctor office. (Croatia, PCP31)
By decreasing bureaucracy! So we will have more 
time for a real consultation! (Romania, PCP49)
The adoption of financial incentives schemes was also 
suggested:
Allocating additional financial resources and stimu-
lating the GP in this direction. (Romania, PCP78)
Financial incentives for preventative care of most 
common malignant conditions. (Bulgaria, PCP4)
PCPs felt that guidelines and protocols needed to be 
clear and relevant to them:
Clear guidelines regarding cancer alarm signs and re-
ferral indications. (Finland, PCP37)
By developing a more specific GP protocol for the 
various types of cancer. (The Netherlands, PCP51)
Fast-track systems for patients with cancer were 
requested by many respondents:
Create a fast-track unit for patients with high cancer 
suspicion. (Spain, PCP51)
In countries where fast-track systems already existed, 
these were seen as a success:
Cancer diagnostics have priority in the Norwegian 
healthcare system since fast-track referral was intro-
duced last year. Functions well. (Norway, PCP5)
I actually think that the introduction of the “2 week 
wait” urgent referral system has greatly improved the 
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speed of diagnosis for those with obvious red flag 
symptoms. (England, PCP11)
Some PCPs felt that there should be more uptake of 
national screening programmes:
Encourage patients to use existing prevention pro-
grammes. (Germany, PCP7)
All physicians should adhere to screening guidelines. 
(Switzerland, PCP8)
Accessing diagnostic tests
This theme suggesting improvements to diagnostic 
structures dealt mainly with easier and quicker access to 
testing. Easier PCP access to diagnostic testing was cited 
by many respondents:
Increasing the range of diagnostics available; also 
making them easier to refer for. (The Netherlands, 
PCP79)
Facilitating family doctors to request tests and investi-
gations that he/she considers necessary for the diag-
nosis. (Spain, PCP39)
Many felt that they should have direct access to 
cancer-specific testing:
GPs should be able to recommend any investiga-
tion without reference to other specialist doctors. 
(Romania, PCP44)
Give GPs the ability to refer patients to more diagnos-
tic tests, for example, CT, tumour markers. (Poland, 
PCP26)
The speed of access to diagnostic tests was also seen as 
key:
Faster access/fast track to imaging diagnostics could 
help us exclude a number of cases and so could re-
lieve specialist services. (Norway, PCP18)
Reduction of the delay in getting special tests. 
(France, PCP 2)
However, some PCPs were worried that the increase 
in investigation of patients needed to diagnose cancers 
earlier could also lead to overdiagnosis and overtreatment:
Cancer diagnostics are a difficult balancing act be-
tween under- and overdiagnosis. Faster cancer diag-
nostics will also give more overdiagnosis. (Norway, 
PCP 31)
Depends on the type of cancer, but there is a trade-off 
between diagnosing a few cancers earlier by refer-
ring lots more patients to specialist clinics and the 
increased stress, anxiety, expense and risk of physical 
harm from unnecessary ionising radiation and treat-
ments. (England, PCP 7)
using information technology
This theme was about using electronic information and 
communication to improve diagnostic capability and 
enhance partnership working. Some PCPs thought that 
more decision support aids should be included in elec-
tronic health records:
Automatic decision support/diagnostic support in 
the GP electronic information system based on symp-
toms. (The Netherlands, PCP10)
The 29 Norwegian guidelines regarding “fast track re-
ferral for cancer” could be included into our electron-
ic patient files as a real decision aid with extraction of 
clinical information for the referral. (Norway, PCP3)
Information technology could also be used to help 
identify those who would benefit from screening, and 
provide reminders relating to individual patients where 
needed:
Select specific age groups from healthcare databas-
es and identify the individuals that haven’t had the 
screening. (Portugal, PCP11)
Using an automatic reminder system for cancer 
screening for each patient. (Greece, PCP15)
Some PCPs were keen on the option to have “virtual 
consultations” with specialists:
Allocating funding to support timely diagnosis
Adequate resources for primary care and targeted 
funding for investigations were frequently recommended 
by participants. This theme wove through the whole 
cancer diagnostic process. An increase in primary care 
financing was considered to be necessary if PCPs were to 
improve access to care:
By increasing resources in primary care in order to 
improve the access to care. (Finland, PCP34)
Adequate funds were also seen to be needed for 
screening and diagnostic tests:
Increase funding of screening tests. (Poland, PCP20)
A higher budget for diagnostic tests, covering … 
some higher costs related to the investigation and 
early diagnosis of cancer. (Romania, PCP59)
In some countries, there was a need for an increase in 
the budget for diagnostic tests and referrals:
Increase funding for cancer diagnostic tests (tumour 
markers, colonoscopy, gastroscopy, radiographs)—
currently, the funding is insufficient. (Poland, PCP29)
Unlimited lab tests and unlimited referrals to spe-
cialist services if malignant conditions are suspected. 
(Bulgaria, PCP11)
Funding limitations could be an issue for patients:
Many patients refuse the investigations because of the 
costs (tumour markers, MRI, extra payment to the 
specialist doctor, ineffective collaboration between 
specialities). (Romania, PCP12)
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This could also affect the finances of the PCPs 
themselves:
Ensure adequate financial support—at present there 
are penalties if the number of consultations exceeds 
the limit, even if the consultations are clinically indi-
cated. (Bulgaria, PCP25)
DIsCussIOn
Principal findings
In this primary care study, participants from 20 countries 
were able to use their experience situated in their own 
healthcare systems to provide a rich variety of sugges-
tions for the improvements needed to allow more timely 
diagnosis of cancer. These covered the whole diagnostic 
pathway, from recommendations on how to help patients 
to present earlier with their symptoms, through continuing 
medical education that would help PCPs to recognise and 
act on symptoms that could be due to cancer, to improving 
communication and interprofessional partnership between 
and within primary and secondary care. Improving health 
system organisation and health policies is essential for 
achieving these goals. Facilitating patients’ access to health-
care was also considered important, as was enabling fast 
and direct PCP access to diagnostic tests. Respondents saw 
funding allocation as an underlying component of most of 
these issues. They also identified a risk that reducing delays 
in cancer diagnosis in some patients could lead to overdiag-
nosis in others.
strengths and weaknesses of the study
This is the first trans-European study to explore PCPs’ 
perceptions of how timeliness of cancer diagnosis can be 
improved, offering a unique insight into the operational 
and administrative challenges. This could be invaluable 
for the evaluation and revision of current healthcare poli-
cies and practices. Cancer diagnosis is a complex process 
and the diagnostic behaviour of PCPs working under the 
influences of their native healthcare systems is a key deter-
minant. A key strength of our work is that we have gath-
ered the views of PCPs from 20 countries in this process; 
our analysis examines systemic influences on PCP cancer 
diagnostic activity across Europe.
Variation in geography, health systems and levels of 
healthcare spending was provided by having four partic-
ipating countries from each of the Central, Eastern, 
Northern, Southern and Western European geograph-
ical areas. The sample size was large and diverse, with 
participants varying in terms of years of clinical practice, 
gender and site and size of practice. The study success-
fully recruited participants in countries in which PCPs are 
under-represented in research.
The survey had only one, short question that related 
directly to our research question. However, it may be that 
this format prompted participants to focus on writing 
down only what, for them, was the most important point. 
Neither patients, secondary care nor other PCPs were 
included in the survey, and these groups may have had 
other insights to offer. There is a risk that the translators 
and investigators misunderstood some of the nuances of 
the 20 different languages, cultures and healthcare organ-
isations involved in this study. While themes were identi-
fied from responses from PCPs in 20 European countries, 
not all of the themes identified will be equally relevant to 
each of the participating countries.
The data collection was completed in December 2016, 
and participating countries’ health systems will have 
continued to develop since then. However, each of the 
themes results from PCPs’ comments on healthcare is 
situated in a society and culture which changes very slowly, 
as is also seen for implementation of new knowledge. The 
findings are therefore likely to continue to be relevant.
Comparison with other studies
Our findings reflect those of a survey of GPs in Ireland, 
which identified that barriers to early cancer diagnosis 
included lack of direct GP access to diagnostic tests, 
difficulties with referral to secondary care, poor clarity 
relating to cancer screening, unequal patient access to 
secondary services and a need for further training and 
guidelines.39 GPs’ views on the importance of closer links 
between primary and secondary care were identified in 
that and other studies.29 30 Our PCPs’ call for improved 
patient education and better access to diagnostic testing 
specialist care were also prioritised by GPs in a UK study.40 
Our findings map across to the findings from qualitative 
research on patient-perceived barriers to early presenta-
tion and diagnosis of cancer, which have identified the 
need for better access to services for patients41 42 and 
better patient awareness of cancer symptoms42 as key 
issues. Our PCPs’ call for an improved partnership with 
other primary healthcare professionals is one that has 
been successfully implemented before, although not 
specifically in relation to cancer diagnosis.43 Their recom-
mendation for better cancer awareness among primary 
care staff is confirmed by evidence from other research 
that there is a need for this.44
GPs in other studies have identified issues that were 
not raised by PCPs in our study, including the percep-
tion that late presentation of cancer symptoms often 
relates to patients’ socioeconomic and sociocultural 
circumstances,15 30 a concern that fragmentation of 
health services adversely affects timeliness of cancer diag-
nosis,15 45 and a need for mentoring of doctors unfamiliar 
with their health systems.30
The need for healthcare systems to support PCPs’ 
quick and easy access to investigations has been proposed 
before.46 While investigation in primary care has been 
linked with later referral for specialist assessment, 
reducing the waiting time for tests would be expected to 
shorten the primary care intervals associated with investi-
gation use.47 Despite this, another study found that some 
patients received a delayed cancer diagnosis, even when 
they had presented with typical cancer symptoms to a GP 
who had access to relevant diagnostic tests.48
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Possible implications for clinicians and policymakers
PCP respondents had specific recommendations on the 
changes that are needed to facilitate more timely diag-
nosis of cancer. Some recommendations, for instance 
health education campaigns and development of rele-
vant guidelines, may need central direction, although 
with the input of PCPs. Others, for example improving 
the way PCPs communicate with secondary care special-
ists, and PCPs’ ability to access to cancer-specific tests, 
may need local agreement. Aspects such as PCPs’ own 
communication skills, their own accessibility to patients 
and their continuing medical education, are more likely 
to be under PCPs’ own control. However, a consideration 
of how funding is best reallocated is crucial if PCPs and 
their health systems are able to make these changes.
unanswered questions and future research
Further analysis is needed to help identify which recom-
mendations are most relevant to different existing models 
of healthcare, for example as to whether some are partic-
ularly relevant to systems in which the PCP has more of 
a “gatekeeper” role, or to those in which PCP practises 
are large or smaller than average. A longitudinal study 
would give evidence on the trends on PCP opinions and 
how they are impacted by changes in health policies and 
public health initiatives. Research using interviews would 
give in-depth ideas on how changes resulting from the 
study findings could be implemented. A mixed-methods 
approach, comparing PCPs’ views from different countries, 
would allow recommendations that are relevant to indi-
vidual countries. In the study we have focused on the view of 
PCPs, as they have a key role in cancer diagnosis throughout 
Europe; however, the views of other stakeholders, such as 
patients and policy makers, are also important and should 
be included in future qualitative research.
There is a need to consider how to get the best 
balance between achieving early cancer diagnosis and 
minimising overdiagnosis of cancer. Our study gives the 
basic elements for the international primary care cancer 
research agenda, which would provide a knowledge base 
for developing and improving cancer diagnosis and prog-
nosis internationally.
COnClusIOns
This research has identified key features that PCPs 
believe would be necessary to improve the timeliness of 
cancer diagnosis in their patients, and a need for re-allo-
cation of health system funding to allow these to happen. 
Health systems need to facilitate earlier patient presenta-
tion through health education and better access to care, 
have well-educated clinicians with good access to investi-
gations and better information technology, and adequate 
primary care cancer diagnostic pathway funding.
Many PCPs play a crucial role at the centre of their 
patients’ care, and the breadth of their experience 
is reflected in their wide range of suggestions. This 
understanding should help to inform health service 
policy and research towards better cancer outcomes.
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